Navigation Links
Fish Oil Doesn't Cut Failure Rate of Hemodialysis Grafts
Date:5/1/2012

TUESDAY, May 1 (HealthDay News) -- Taking fish-oil supplements does not significantly lower the failure rate of grafts used for hemodialysis, a new study finds.

The study included about 200 North American kidney-failure patients with a synthetic tube grafted between an artery and a vein, which provides access to the bloodstream for hemodialysis, a process in which waste products are removed from the blood.

The patients were randomly assigned to take fish-oil capsules or a placebo daily for one year, starting one week after the graft was created.

During that time, there was no statistically significant difference between the two groups in the proportion of grafts that failed to remain open, according to researchers at the University of Toronto and Toronto General Hospital.

Patients taking fish oil were less likely to develop blood clots, however, and went a longer time without developing blood clots. The fish-oil group also had a lower rate of radiological and surgical interventions.

The study appears in the May 2 issue of the Journal of the American Medical Association.

The patients in the study had an arteriovenous graft, which was the leading method for gaining vascular access among hemodialysis patients in North America in the early 1990s, according to the study.

But that type of graft fell out of favor due to its high complication rates and associated costs. It has been suggested that omega-3 fatty acids found in fish oils might help prevent arteriovenous graft complications.

These findings do not support this theory, an expert wrote in an editorial that accompanied the study.

Instead, another type of graft -- arteriovenous fistula -- is the preferred method, wrote Dr. Bradley Dixon, of the University of Iowa in Iowa City.

"However, if a patient cannot obtain a fistula and requires a graft, use of fish oil and an antiplatelet agent appears reasonable, pending the results of further studies," Dixon wrote.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about hemodialysis.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, May 1, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Lymph Node Test Doesnt Improve Breast Cancer Care, Study Finds
2. Compound shows promise against intractable heart failure
3. The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies Failure to Provide Adequate Safety Research
4. Blacks, Hispanics With Heart Failure Less Likely to Use Hospice
5. Bipartisan Capitol Hill Media Event: Health Experts, Lawmakers to Urge Federal Government to Fix the Funding Failure for Chronic Viral Hepatitis
6. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Louisiana is 46th Among All States in Maternal Mortality
7. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality
8. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Maryland is 48th Among All States in Maternal Mortality
9. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; District of Columbia is 51st Among All States in Maternal Mortality
10. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Arkansas is 44th Among All States in Maternal Mortality
11. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Delaware is 42nd Among All States in Maternal Mortality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on ... later, the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his ... the hospital’s 30th heart transplant recipient. , “He was playing at home, when we ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... AlignLife clinics nationwide ... Many children are not fortunate enough to receive bountiful gifts wrapped tightly under a ... can bring to the children of the world. , In exchange for generous donations, ...
(Date:12/7/2016)... OR (PRWEB) , ... December 07, 2016 , ... Sharon ... Water, Global Climate Change and Your Health on Voice of America, declared on her ... to call attention to the fact that when these bullies attack leaders in corporate ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers ... Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, ... with Delightful Deals on Botox® and Juvederm® just in time for the ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Research and Markets has announced the addition of the ... to 2021" report to their offering. ... , , The immunohistochemistry (IHC) ... a CAGR of 7.3% during the forecast period of 2016 to 2021. ... rapidly increasing geriatric population across the globe are the primary driving the ...
(Date:12/7/2016)... 7, 2016  Palatin Technologies, Inc. ("Palatin") (NYSE ... a previously disclosed underwritten public offering of units ... as sole book-running manager, Roth Capital Partners acted ... as co-manager for the offering. "This ... net proceeds, allowing us to continue advancing bremelanotide ...
(Date:12/7/2016)... , Dec. 7, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Janus Kinase 3 (JAK3) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
Breaking Medicine Technology: